Isolation and Structure of Spongistatin 1

Journal of Organic Chemistry

Volumn 58, Issue 6, 1993, Pages 1302-1304

  Pettit, George R ^a   Cichacz, Zbigniew A ^a   Gao, Feng ^a   Herald, Cherry L ^a   Boyd, Michael R ^a,b   Schmidt, Jean M ^a   Hooper, John N A ^a,c  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Northern Territory Museum of Arts and Sciences   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSTATIC AGENT; MACROLIDE; SPONGISTATIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; LEUKEMIA P 388 CELL; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; SPONGE; TUMOR CELL;

EID: 0027155835     PISSN: 00223263     EISSN: 15206904     Source Type: Journal    
DOI: 10.1021/jo00058a004     Document Type: Article

References (22)

1. Antineoplastic agents 257. For contribution 256 refer to: Pettit, G. R.; Pettit, G. R., III; Backhaus, R. A.; Boyd, M. R.; Meerow, A. W. J. Nat. Prod., submitted.
2. Pettit, G. R.; Day, J. F.; Hartwell, J. L.; Wood, H. B. Nature 1970, 227, 962.
3. Pettit, G. R.; Gao, F.; Sengupta, D.; Coll, J. C.; Herald, C. L.; Doubek, D. L.; Schmidt, J. M.; Van Camp, J. R.; Rudloe, J. J.; Nieman, R. A. Tetrahedron 1991, 47, 3601.
4. Pettit, G. R. The Bryostatins. In Progress in the Chemistry of Organic Natural Products; No. 57, Founded by Zechmeister, L.; Herz, W., Kirby, G. W., Steglich, W., Tamm, Ch., Eds.; Springer-Verlag: New York, 1991; pp 153–195.
5. Pettit, G. R.; Herald, C. L.; Boyd, M. R.; Leet, J. E.; Dufresne, C.; Doubek, D. L.; Schmidt, J. M.; Cerny, R. L.; Hooper, J. N. A.; Rützler, K. C. J. Med. Chem. 1991, 34, 3339.
6. Kato, Y.; Fusetani, N.; Matsunaga, S.; Hashimoto, K.; Sakai, R.; Higa, T.; Kashman, Y. Tetrahedron Lett. 1987, 28, 6225.
7. Tanaka, J.; Higa, T.; Kobayashi, M.; Kitagawa, I. Chem. Pharm. Bull. 1990, 38, 2967.
8. Kobayashi, M.; Tanaka, J.; Katori, T.; Matsuura, M.; Kitagawa, I. Tetrahdron Lett. 1989, 30, 2963.
9. Kobayashi, M.; Tanaka, J.; Katori, T.; Kitagawa, I. Chem. Pharm. Bull. 1990, 38, 2960.
10. Kitagawa, I.; Kobayashi, M.; Katori, T.; Yamashita, M.; Tanaka, J.; Doi, M.; Ishida, T. J. Am. Chem. Soc. 1990, 112, 3710.
11. Doi, M.; Ishida, T.; Kobayashi, M.; Kitagawa, I. J. Org. Chem. 1991, 56, 3629.
12. Tsukamoto, S.;Ishibashi, M.; Sasaki, T.; Kobayashi, J. J. Chem. Soc., Perkin Trans. 1 1991, 3185.
13. Todd, J. S.; Alvi, K. A.; Crews, P. Tetrahedron Lett. 1992, 33, 441.
14. Pham, A. T.; Carney, J. R.; Yoshida, W. Y.; Scheuer, P. J. Tetrahedron Lett. 1992, 33, 1147.
15. Gonzales, A. G.; Estrada, D. M.; Martin, J. D.; Martin, V. S.; Perez, C.; Perez, R. Tetrahedron 1984, 40, 4109.
16. Cimino, G.; Morrone, R.; Sodano, G. Tetrahedron Lett. 1982, 23, 4139.
17. Cimino, G.; De Rosa, S.; De Stefano, S. Experientia 1981, 37, 214.
18. Walker, R. P.; Thompson, J. E.; Faulkner, D. J. J. Org. Chem. 1980, 45, 4876.
19. Capelle, N.; Braekman, J. C.; Daloze, D.; Tursch, B. Bull. Soc. Chim. Belg. 1980, 89, 399.
20. Kazlauskas, R.; Murphy, P. T.; Wells, R. J.; Noack, K.; Oberhänsli, W. E.; Schönholzer, P. Aust. J. Chem. 1979, 32, 867.
21. Boyd, M. R. Status of the NCI preclinical antitumor drug discovery screen. In Principles and Practices of Oncology Updates; DeVita, V. T., Jr., Hellman, S., Rosenberg, S. A., Eds.; Lippincott: Philadelphia, 1989; Vol. 10, No. 3, pp 1–12.
22. Boyd, M. R.; Pauli, K. D.; Rubinstein, L. R. Data display and analysis strategies from the NCI disease-oriented in vitro antitumor drug screen. In Antitumor Drug Discovery and Development; Valeriote, F. A.; Corbett, T.; Baker, L., Eds.; Kluwer Acedemic Press: Amsterdam, 1990; in press.